Eric Thorin

Founder at Gene Signal International SA

Health Technology

Process Industries

Profile

Eric Thorin is the founder of Gene Signal International SA, a company founded in 2000.
He holds the title of Director & Chief Development Officer at Gene Signal International SA. Dr. Thorin also held the position of Head-Cardiovascular Pharmacology at Actelion Pharmaceuticals, Inc. (France).

Eric Thorin active positions

Companies	Position	Start
Gene Signal International SA Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland.	Founder	1999-12-31

All active positions of Eric Thorin

Former positions of Eric Thorin

Companies	Position	End
Actelion Pharmaceuticals, Inc. (France) Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig.	Corporate Officer/Principal	-

See the detail of Eric Thorin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eric Thorin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Gene Signal International SA Gene Signal International SA Pharmaceuticals: MajorHealth Technology Gene Signal International SA engages in the development of drugs to manage angiogenesis based conditions. It is a research based biotechnology company specialized in the discovery, development, and commercialization of a new class of oligonucleotides, proteins and monoclonal antibodies to treat a range of conditions where angiogenesis plays a determinant role. The company was founded by Eric Viaud, Salman Al-Mahmood, and Eric Thorin in 2000 and is headquartered in Lausanne, Switzerland.	Health Technology
Actelion Pharmaceuticals, Inc. (France) Actelion Pharmaceuticals, Inc. (France) Industrial SpecialtiesProcess Industries Actelion Pharmaceuticals, Inc. (France) is a private company based in Le Pin, France. and has subsidiaries in France. Actelion Pharmaceuticals, Inc. manufactures insulation materials. The French company was founded by Annick Schwebig.	Process Industries